NACDS is urging Congress to keep pharmacies and pharmacy teams top-of-mind as legislators continue to evaluate and respond to the lessons of the COVID-19 pandemic.
That is the case on Wednesday, March 2, as the Oversight and Investigations Subcommittee of the U.S. House of Representatives Energy and Commerce Committee holds a hearing titled, “Lessons from the Frontline: COVID-19’s Impact on American Health Care.”
The hearing comes on the heels of a poll conducted February 15-16, 2022, by Morning Consult and commissioned by NACDS*, which found:
- Two-in-three adults (68%) rate pharmacies’ response to COVID-19 as excellent or good – only two points behind hospitals which top the list of entities tested.
- When thinking about healthcare, over four-in-five (86%) of adults indicate that it is easy to access pharmacies – positioning them as the most accessible entities tested.
- Four-in-five adults say they have a favorable opinion of their pharmacist (80%).
NACDS also has issued three reports detailing lessons learned and recommendations from the pandemic:
- Community Retail Pharmacies’ Experience during the COVID-19 Response: Successes and Lessons Learned to Date (joint report with Health Preparedness Partners)
- Accelerating the Center for Medicare and Medicaid Innovation’s Mission: Integrating Pharmacy Care into Value-Based Programs Amid COVID-19 Pandemic Recovery and Beyond (joint report with CapView Strategies)
- Striving Toward Health Equity in COVID-19: The Role of Pharmacies in a National Response (joint report with the Johns Hopkins Center for Health Security)
NACDS emphasizes key government statistics regarding the role of pharmacies in the COVID-19 response:
- Pharmacies have given more than 229 million COVID-19 vaccinations as of February 9, 2022.
- Pharmacies have operated more than 20,000 COVID-19 testing sites nationwide.
- Pharmacies provide more than 2 of every 3 COVID-19 vaccine doses.
- More than 30 percent of children ages 5 to 11 who have received their COVID-19 vaccination have done so at a pharmacy.
- Half of pharmacy COVID-19 vaccination sites are located in areas with high social vulnerability.
- 70% of pharmacy testing sites are in areas with moderate to severe social vulnerability.
- More than 40% of those vaccinated at pharmacies are from racial and ethnic minority groups.
NACDS President and CEO Steven C. Anderson issued the following statement related to the hearing:
“NACDS commends Energy and Commerce Committee Chairman Frank Pallone, Jr. (D-NJ) and Oversight and Investigations Subcommittee Chair Diana DeGette (D-CO) for holding this hearing.
“The COVID-19 pandemic showed again that pharmacy comes through for the American people. Congress is reviewing pandemic preparedness. It is studying what the pandemic’s lessons mean for other aspects of healthcare – including the prevention and management of chronic disease. The trust, accessibility and equity of pharmacies and pharmacy teams must remain central to that discussion, just as they remain central to this pandemic’s response.
“Throughout the pandemic, pharmacies stayed open – lights on, doors open. Pharmacy teams filled gaps in care when other healthcare destinations and professionals were overrun. They ramped up COVID-19 testing as well as vaccinations for COVID-19 and flu – and for other important vaccinations that were not otherwise readily accessible. They adapted swiftly to rapidly changing government priorities. They now present tremendous capabilities to smooth the patient journey for COVID-19 antivirals. Their accessibility and equity – with a pharmacy within five miles of 90 percent of Americans – bring game-changing capabilities.
“From a global pandemic to meeting people’s day-to-day emergencies, pharmacies remain the face of neighborhood healthcare. Policies that have empowered their preparedness must not be rolled back, and must be enhanced for the ultimate benefit of all Americans. The National Association of Chain Drug Stores looks forward to working with Congress and with the Administration to ensure that is the case.”
More information is available at NACDS.org/COVID-19.
*Methodology: This poll was conducted between February 15 and February 16, 2022 among a sample of 2,210 Adults. The interviews were conducted online and the data were weighted to approximate a target sample of Adults based on gender, educational attainment, age, race, and region. Results from the full survey have a margin of error of plus or minus 2 percentage points.
